$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2019 Q4 Form 10-K Financial Statement

#000139681420000008 Filed on February 21, 2020

Income Statement

Concept	2019 Q4	2019 Q3	2019 Q2
Revenue	$122.4M	$104.7M	$102.6M
YoY Change	28.71%	25.45%	21.99%
Cost Of Revenue	$31.90M	$22.30M	$25.20M
YoY Change	33.05%	16.99%	20.49%
Gross Profit	$90.52M	$82.38M	$77.40M
YoY Change	27.25%	27.95%	22.49%
Gross Profit Margin	73.94%	78.69%	75.44%
Selling, General & Admin	$54.20M	$50.13M	$49.13M
YoY Change	21.52%	13.47%	11.02%
% of Gross Profit	59.88%	60.85%	63.47%
Research & Development	$19.70M	$20.26M	$17.83M
YoY Change	38.73%	35.97%	45.66%
% of Gross Profit	21.76%	24.59%	23.03%
Depreciation & Amortization	$5.090M	$3.600M	$3.500M
YoY Change	25.37%	2.86%	25.0%
% of Gross Profit	5.62%	4.37%	4.52%
Operating Expenses	$120.7M	$102.3M	$97.33M
YoY Change	45.69%	28.81%	25.48%
Operating Profit	-$30.19M	$2.413M	$5.275M
YoY Change	157.69%	-40.39%	-19.35%
Interest Expense	-$4.300M	$5.940M	$5.878M
YoY Change	13.16%	5.28%	8.91%
% of Operating Profit		246.17%	111.43%
Other Income/Expense, Net	-$900.0K	-$8.229M	-$4.148M
YoY Change	350.0%	73.24%	5.23%
Pretax Income	-$3.500M	-$5.816M	$1.127M
YoY Change	-142.17%	728.49%	-56.64%
Income Tax	$1.300M	$300.0K	-$1.600M
% Of Pretax Income			-141.97%
Net Earnings	-$4.888M	-$6.087M	$2.730M
YoY Change	-159.0%	851.09%	6.47%
Net Earnings / Revenue	-3.99%	-5.81%	2.66%
Basic Earnings Per Share	-$0.12	-$0.15	$0.07
Diluted Earnings Per Share	-$0.12	-$0.15	$0.06
COMMON SHARES
Basic Shares Outstanding	41.73M shares	41.65M shares	41.38M shares
Diluted Shares Outstanding		41.65M shares	42.35M shares

Balance Sheet

Concept	2019 Q4	2019 Q3	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$292.0M	$265.6M	$292.2M
YoY Change	-23.86%	-31.26%	-21.3%
Cash & Equivalents	$78.23M	$85.14M	$59.74M
Short-Term Investments	$213.7M	$180.5M	$232.5M
Other Short-Term Assets	$10.80M	$10.40M	$8.500M
YoY Change	36.71%	60.0%	41.67%
Inventory	$58.30M	$60.24M	$52.70M
Prepaid Expenses
Receivables	$47.53M	$42.57M	$41.15M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$408.6M	$378.8M	$394.6M
YoY Change	-14.52%	-19.74%	-13.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$104.7M	$104.9M	$105.5M
YoY Change	-3.67%	-4.73%	-5.2%
Goodwill	$99.55M	$99.55M	$100.5M
YoY Change	60.46%	60.46%	67.81%
Intangibles	$104.4M	$106.4M	$108.3M
YoY Change
Long-Term Investments	$10.00M	$82.10M	$42.40M
YoY Change	-75.0%	482.27%	170.06%
Other Assets
YoY Change
Total Long-Term Assets	$422.5M	$428.6M	$393.2M
YoY Change	99.88%	129.23%	109.58%
TOTAL ASSETS
Total Short-Term Assets	$408.6M	$378.8M	$394.6M
Total Long-Term Assets	$422.5M	$428.6M	$393.2M
Total Assets	$831.1M	$807.5M	$787.8M
YoY Change	20.56%	22.52%	22.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.80M	$16.06M	$13.35M
YoY Change	-10.92%	16.45%	-6.4%
Accrued Expenses	$70.43M	$61.00M	$51.91M
YoY Change	53.55%	51.15%	35.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$107.7M	$95.84M	$83.00M
YoY Change	77.5%	75.78%	56.54%
LONG-TERM LIABILITIES
Long-Term Debt	$306.0M	$302.1M	$298.2M
YoY Change	5.3%	5.3%	5.26%
Other Long-Term Liabilities	$1.502M	$2.320M	$8.993M
YoY Change	-91.1%	-85.82%	-43.39%
Total Long-Term Liabilities	$1.502M	$2.320M	$8.993M
YoY Change	-91.1%	-85.82%	-43.39%
TOTAL LIABILITIES
Total Short-Term Liabilities	$107.7M	$95.84M	$83.00M
Total Long-Term Liabilities	$1.502M	$2.320M	$8.993M
Total Liabilities	$476.1M	$461.3M	$446.2M
YoY Change	29.34%	28.94%	26.7%
SHAREHOLDERS EQUITY
Retained Earnings	-$399.4M	-$394.5M	-$388.4M
YoY Change	2.88%	-0.5%	-1.88%
Common Stock	$42.00K	$42.00K	$42.00K
YoY Change	2.44%	2.44%	2.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares		0.000 shares	0.000 shares
Shareholders Equity	$354.9M	$346.2M	$341.7M
YoY Change
Total Liabilities & Shareholders Equity	$831.1M	$807.5M	$787.8M
YoY Change	20.56%	22.52%	22.59%

Cashflow Statement

Concept	2019 Q4	2019 Q3	2019 Q2
OPERATING ACTIVITIES
Net Income	-$4.888M	-$6.087M	$2.730M
YoY Change	-159.0%	851.09%	6.47%
Depreciation, Depletion And Amortization	$5.090M	$3.600M	$3.500M
YoY Change	25.37%	2.86%	25.0%
Cash From Operating Activities	$25.90M	$18.36M	$22.76M
YoY Change	22.05%	10.4%	66.01%
INVESTING ACTIVITIES
Capital Expenditures	-$4.500M	-$1.590M	-$2.050M
YoY Change	100.89%	-64.27%	-22.35%
Acquisitions
YoY Change
Other Investing Activities	-$26.30M	$7.220M	-$179.8M
YoY Change	-78.25%	-92.7%	-388.94%
Cash From Investing Activities	-$30.80M	$5.630M	-$181.8M
YoY Change	-74.99%	-94.04%	-405.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.020M	1.420M	3.740M
YoY Change	-157.39%	-52.51%	85.15%
NET CHANGE
Cash From Operating Activities	25.90M	18.36M	22.76M
Cash From Investing Activities	-30.80M	5.630M	-181.8M
Cash From Financing Activities	-2.020M	1.420M	3.740M
Net Change In Cash	-6.920M	25.41M	-155.3M
YoY Change	-92.97%	-77.73%	-306.24%
FREE CASH FLOW
Cash From Operating Activities	$25.90M	$18.36M	$22.76M
Capital Expenditures	-$4.500M	-$1.590M	-$2.050M
Free Cash Flow	$30.40M	$19.95M	$24.81M
YoY Change	29.58%	-5.36%	51.74%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019	dei	Amendment Flag AmendmentFlag	false
CY2019	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2019	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2019Q4	pcrx	Sharebased Compensationarrangementby Sharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue SharebasedCompensationarrangementbySharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue	41.87
CY2019Q4	pcrx	Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue	28591000	USD
CY2017	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2018	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.21
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41222799	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	41908148	shares
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019	dei	Document Annual Report DocumentAnnualReport	true
CY2019	dei	Document Period End Date DocumentPeriodEndDate	2019-12-31
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019	dei	Document Type DocumentType	10-K
CY2019	dei	Document Transition Report DocumentTransitionReport	false
CY2019	dei	Entity File Number EntityFileNumber	001-35060
CY2019	dei	Entity Registrant Name EntityRegistrantName	PACIRA BIOSCIENCES, INC.
CY2019	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2019	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	51-0619477
CY2019	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Sylvan Way, Suite 300
CY2019	dei	Entity Address City Or Town EntityAddressCityOrTown	Parsippany,
CY2019	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2019	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07054
CY2019	dei	City Area Code CityAreaCode	(973)
CY2019	dei	Local Phone Number LocalPhoneNumber	254-3560
CY2019	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2019	dei	Trading Symbol TradingSymbol	PCRX
CY2019	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2019	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2019	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2019	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2019	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2019	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019	dei	Entity Small Business EntitySmallBusiness	false
CY2019	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019	dei	Entity Shell Company EntityShellCompany	false
CY2019Q2	dei	Entity Public Float EntityPublicFloat	848300000	USD
CY2020Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	42033039	shares
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2019Q4	us-gaap	Short Term Investments ShortTermInvestments	213722000	USD
CY2018Q4	us-gaap	Short Term Investments ShortTermInvestments	250928000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	47530000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	38000000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	58296000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	48569000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10781000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7946000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	408557000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	477969000	USD
CY2019Q4	us-gaap	Long Term Investments LongTermInvestments	64798000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108670000	USD
CY2018Q4	us-gaap	Long Term Investments LongTermInvestments	25871000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104681000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	38124000	USD
CY2018Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62040000	USD
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	104387000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2019Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	10971000	USD
CY2018Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14803000	USD
CY2019Q4	us-gaap	Assets Assets	831065000	USD
CY2018Q4	us-gaap	Assets Assets	689353000	USD
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12799000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14368000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70427000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45865000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4935000	USD
CY2018Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	USD
CY2019Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2018Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	338000	USD
CY2019Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	18179000	USD
CY2018Q4	pcrx	Contingent Consideration Current ContingentConsiderationCurrent	0	USD
CY2019Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	1333000	USD
CY2018Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	90000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	107673000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	60661000	USD
CY2019Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	306045000	USD
CY2018Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	290592000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	40938000	USD
CY2018Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	USD
CY2019Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	19963000	USD
CY2018Q4	pcrx	Contingent Consideration Noncurrent ContingentConsiderationNoncurrent	0	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1502000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16874000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	476121000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	368127000	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	42000	USD
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	753978000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	709691000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-399398000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-388226000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	322000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-280000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	831065000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	689353000	USD
CY2019	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	0	USD
CY2018	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3000000	USD
CY2017	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	387000	USD
CY2019	us-gaap	Revenues Revenues	421026000	USD
CY2018	us-gaap	Revenues Revenues	337277000	USD
CY2017	us-gaap	Revenues Revenues	286630000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	106712000	USD
CY2018	us-gaap	Cost Of Revenue CostOfRevenue	86845000	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	87915000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	72119000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	55688000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57290000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	200782000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	177265000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	161494000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5703000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2019	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	25230000	USD
CY2018	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	1564000	USD
CY2017	pcrx	Acquisition Related Charges Product Discontinuation And Other Expenses AcquisitionRelatedChargesProductDiscontinuationAndOtherExpenses	4868000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	410546000	USD
CY2018	us-gaap	Operating Expenses OperatingExpenses	321362000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	311567000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	10480000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	15915000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-24937000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	7376000	USD
CY2018	us-gaap	Investment Income Interest InvestmentIncomeInterest	6497000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	4078000	USD
CY2019	us-gaap	Interest Expense InterestExpense	23628000	USD
CY2018	us-gaap	Interest Expense InterestExpense	21949000	USD
CY2017	us-gaap	Interest Expense InterestExpense	18047000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3732000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4976000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-888000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	167000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21228000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16340000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17534000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10748000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-425000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42471000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	268000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	140000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-42611000	USD
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.07
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	41513000	shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40911000	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39806000	shares
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-42611000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	602000	USD
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	174000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-424000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	602000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	174000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-424000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-10414000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-297000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43035000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	218976000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6778000	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1862000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31601000	USD
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	120960000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-424000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-42611000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1361000	USD
CY2018	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7170000	USD
CY2018	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1784000	USD
CY2018	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31725000	USD
CY2018	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	174000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	321226000	USD
CY2019Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-156000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8469000	USD
CY2019	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2019	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2402000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33650000	USD
CY2019	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	602000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	354944000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-42611000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	19576000	USD
CY2018	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13165000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13833000	USD
CY2019	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1707000	USD
CY2018	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1590000	USD
CY2017	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1248000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13746000	USD
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	12799000	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10423000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-1010000	USD
CY2018	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-65000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2133000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3732000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	33650000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	31725000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	31601000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	16672000	USD
CY2018	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2017	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2019	us-gaap	Gain Loss On Investments GainLossOnInvestments	-4315000	USD
CY2018	us-gaap	Gain Loss On Investments GainLossOnInvestments	-854000	USD
CY2017	us-gaap	Gain Loss On Investments GainLossOnInvestments	0	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8524000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5999000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1721000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8026000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7157000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10133000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3885000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3228000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3476000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1822000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-573000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5712000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	20213000	USD
CY2018	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5203000	USD
CY2017	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3647000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6726000	USD
CY2018	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	897000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3555000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	370000	USD
CY2018	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	0	USD
CY2017	us-gaap	Payment For Contingent Consideration Liability Operating Activities PaymentForContingentConsiderationLiabilityOperatingActivities	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	70520000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48870000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	17785000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	117691000	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10159000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14514000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19266000	USD
CY2019	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	318484000	USD
CY2018	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	363255000	USD
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	502752000	USD
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	319468000	USD
CY2018	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	405188000	USD
CY2017	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	321713000	USD
CY2019	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	0	USD
CY2018	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	6843000	USD
CY2017	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	8460000	USD
CY2017	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	15000000	USD
CY2019	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	1622000	USD
CY2018	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-128488000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	20576000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-223765000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8469000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7170000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6778000	USD
CY2019	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2402000	USD
CY2018	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1784000	USD
CY2017	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1862000	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2018	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2017	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000	USD
CY2019	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	338000	USD
CY2017	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	118193000	USD
CY2019	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	233000	USD
CY2018	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	0	USD
CY2017	pcrx	Payments For Debt Conversion Premiums PaymentsForDebtConversionPremiums	0	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	6630000	USD
CY2018	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2017	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000000	USD
CY2019	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2018	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2017	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	285000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3670000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8954000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	224162000	USD
CY2019	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-54298000	USD
CY2018	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	78400000	USD
CY2017	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	18182000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	78228000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132526000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	129000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	8199000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	8205000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	6896000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	863000	USD
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	128000	USD
CY2019	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	0	USD
CY2018	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	0	USD
CY2017	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	120960000	USD
CY2019	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2018	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2017	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	126328000	USD
CY2019	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	125000	USD
CY2018	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	-98000	USD
CY2017	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	2189000	USD
CY2019	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	28470000	USD
CY2018	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	0	USD
CY2017	pcrx	Increase Decrease In Contingent Consideration IncreaseDecreaseInContingentConsideration	0	USD
CY2019	us-gaap	Use Of Estimates UseOfEstimates	<div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</span></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, inventory costs, impairments of equity investments, long-lived assets, goodwill, liabilities and accruals, including contingent consideration, and the valuation of deferred tax assets. The Company’s critical accounting policies are those that are both most important to the Company’s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</span></div>
CY2019Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	28500000	USD
CY2018Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	40600000	USD
CY2018Q4	us-gaap	Commercial Paper At Carrying Value CommercialPaperAtCarryingValue	21400000	USD
CY2018Q4	us-gaap	Asset Backed Securities At Carrying Value AssetBackedSecuritiesAtCarryingValue	4900000	USD
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	19193000	USD
CY2018Q2	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	100000	USD
CY2019	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Recent Accounting Pronouncements Not Adopted as of December 31, 2019</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="font-family:inherit;font-size:10pt;">, which required entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. The Company now includes forward-looking information to better form its credit loss estimates. This update also required enhanced disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. This standard is effective for the Company beginning January 1, 2020. The Company does not believe the adoption of this standard will have a material impact on its consolidated statements of operations, stockholders’ equity or cash flows.</span></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-13, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fair Value Measurement (Topic 820): Disclosure Framework. </span><span style="font-family:inherit;font-size:10pt;">The update added the following disclosures: (i) changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. The standard will become effective for the Company beginning January 1, 2020. The Company will apply these new disclosure requirements in its consolidated financial statements beginning with the three-month period ending March 31, 2020.</span></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div><div style="line-height:120%;padding-bottom:13px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In August 2018, the FASB issued ASU 2018-15, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Intangibles—Goodwill and Other Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract</span><span style="font-family:inherit;font-size:10pt;">, which aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The update provides guidance to determine which implementation costs to capitalize as they relate to the service contract and which costs to expense. In addition, the update further defines the term of the hosting arrangement to include the non-cancelable period of the arrangement plus periods covered by (i) an option to extend the arrangement if the customer is reasonably certain to exercise that option; (ii) an option to terminate the arrangement if the customer is reasonably certain not to exercise the termination option and (iii) an option to extend (or not to terminate) the arrangement in which exercise of the option is in the control of the vendor. Any expense related to the capitalized implementation costs should be recorded in the same financial statement line item in the consolidated statements of operations as the fees associated with the hosting element of the arrangement, and the payments for capitalized implementation costs should be classified in the same manner as payments made for fees associated with the hosting element in the consolidated statements of cash flows. This standard is effective for the Company beginning January 1, 2020. The amendments could be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption. The Company has applied this standard prospectively to its implementation costs incurred beginning in 2020. Any new implementation costs incurred are classified in other assets and the amortization classified in operating expenses, separate from depreciation expense, over the term of the hosting arrangement.</span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In December 2019, the FASB issued ASU 2019-12, </span><span style="font-family:inherit;font-size:10pt;font-style:italic;">Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes, </span><span style="font-family:inherit;font-size:10pt;">which amends the approaches and methodologies in accounting for income taxes during interim periods and makes changes to certain income tax classifications. The new standard allows exceptions to the use of the incremental approach for intra-period tax allocation, when there is a loss from continuing operations and income or a gain from other items, and to the general methodology for calculating income taxes in an interim period, when a year-to-date loss exceeds the anticipated loss for the year. The standard also requires franchise or similar taxes partially based on income to be reported as income tax and the effects of enacted changes in tax laws or rates to be included in the annual effective tax rate computation from the date of enactment. Lastly, in any future acquisition, the Company would be required to evaluate when the step-up in the tax basis of goodwill is part of the business combination and when it should be considered a separate transaction. The standard will be effective for the Company beginning January 1, 2021, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2019-12 on its consolidated financial statements.</span></div>
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3800000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	15581000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	16368000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3013000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	19321000	USD
CY2018	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	19034000	USD
CY2018Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3300000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	26951000	USD
CY2019	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	25447000	USD
CY2019Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	4804000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	418926000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	332427000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	284342000	USD
CY2019Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	20019000	USD
CY2019Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14407000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	9711000	USD
CY2019Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	23870000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	19665000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	58296000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	48569000	USD
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1300000	USD
CY2019Q4	pcrx	Inventory Potential Unsellable Amount InventoryPotentialUnsellableAmount	4400000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	180121000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	170228000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	75440000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	61558000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	104681000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108670000	USD
CY2019	us-gaap	Depreciation Depreciation	14000000.0	USD
CY2018	us-gaap	Depreciation Depreciation	13200000	USD
CY2017	us-gaap	Depreciation Depreciation	13800000	USD
CY2018	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	700000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1100000	USD
CY2019Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	64800000	USD
CY2018Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	64600000	USD
CY2019Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2500000	USD
CY2018Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	2200000	USD
CY2019	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	300000	USD
CY2019	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	200000	USD
CY2018	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	100000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	6225000	USD
CY2018	us-gaap	Operating Lease Cost OperatingLeaseCost	7236000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	1651000	USD
CY2018	us-gaap	Variable Lease Cost VariableLeaseCost	1761000	USD
CY2019	us-gaap	Lease Cost LeaseCost	7876000	USD
CY2018	us-gaap	Lease Cost LeaseCost	8997000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	7346000	USD
CY2019	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	41605000	USD
CY2019Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M17D
CY2019Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0755
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	8223000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6239000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5875000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	6013000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	6155000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	32830000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	65335000	USD
CY2019Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19462000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	45873000	USD
CY2019	pcrx	Lessee Operating Lease Lease Not Yet Commenced Number Of Contracts LesseeOperatingLeaseLeaseNotYetCommencedNumberOfContracts	1	contract
CY2019Q4	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Next Twelve Months LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueNextTwelveMonths	2159000	USD
CY2019Q4	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Two LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearTwo	4415000	USD
CY2019Q4	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Three LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearThree	4548000	USD
CY2019Q4	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Four LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFour	4684000	USD
CY2019Q4	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Year Five LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueYearFive	4825000	USD
CY2019Q4	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Due Thereafter LesseeOperatingLeaseLeaseNotYetCommencedLiabilityDueThereafter	29242000	USD
CY2019Q4	pcrx	Lessee Operating Lease Lease Not Yet Commenced Liability Payments Due LesseeOperatingLeaseLeaseNotYetCommencedLiabilityPaymentsDue	49873000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	8140000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	7621000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5295000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5417000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5543000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	14329000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	46345000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	55197000	USD
CY2018	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	6843000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	62040000	USD
CY2019	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	37507000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	99547000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	110090000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5703000	USD
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	104387000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	0	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5700000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2019Q4	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount From2020 To2032 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountFrom2020To2032	7900000	USD
CY2019Q3	pcrx	Finite Lived Intangible Assets Amortization Expense Annual Amount In2033 FiniteLivedIntangibleAssetsAmortizationExpenseAnnualAmountIn2033	2200000	USD
CY2019Q4	pcrx	Accruedsellinggeneralandadministrativeexpenses Accruedsellinggeneralandadministrativeexpenses	21695000	USD
CY2018Q4	pcrx	Accruedsellinggeneralandadministrativeexpenses Accruedsellinggeneralandadministrativeexpenses	14419000	USD
CY2019Q4	pcrx	Accruedresearchanddevelopmentexpenses Accruedresearchanddevelopmentexpenses	6562000	USD
CY2018Q4	pcrx	Accruedresearchanddevelopmentexpenses Accruedresearchanddevelopmentexpenses	2432000	USD
CY2019Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	12955000	USD
CY2018Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	4281000	USD
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	22258000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18861000	USD
CY2019Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2883000	USD
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2286000	USD
CY2019Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2048000	USD
CY2018Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2053000	USD
CY2019Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	2026000	USD
CY2018Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	1533000	USD
CY2019Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	70427000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	45865000	USD
CY2017Q1	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2019Q1	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	300000	USD
CY2019Q1	pcrx	Repaymentof Conversion Premium RepaymentofConversionPremium	200000	USD
CY2019	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	20000	USD
CY2018	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	689000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1101000	USD
CY2019Q4	us-gaap	Share Price SharePrice	45.30
CY2019Q4	pcrx	Total Milestone Payments Yet To Be Paidin Connectionwith Myo Science Acquisition TotalMilestonePaymentsYetToBePaidinConnectionwithMyoScienceAcquisition	73000000.0	USD
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	7000000	USD
CY2019Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	10000000.0	USD
CY2018Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	14100000	USD
CY2019Q2	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	1600000	USD
CY2019	us-gaap	Dividend Income Operating DividendIncomeOperating	2500000	USD
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	5700000	USD
CY2018	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	900000	USD
CY2019	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2018	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41908148	shares
CY2018Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	41222799	shares
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q2	pcrx	Sharebased Compensation Arrangementby Sharebased Payment Award Increase In Numberof Shares Authorized SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseInNumberofSharesAuthorized	3000000	shares
CY2019Q4	pcrx	Employee Stock Purchase Plan Espp Sharesin Espp EmployeeStockPurchasePlanESPPSharesinESPP	500000	shares
CY2019Q4	pcrx	Maximum Fair Market Value Purchaseof Espp Shares MaximumFairMarketValuePurchaseofESPPShares	25000	USD
CY2019Q4	pcrx	Employee Stock Purchase Planfairvalue EmployeeStockPurchasePlanfairvalue	0.85
CY2019	pcrx	Stock Purchased And Issued During Period Shares Employee Stock Purchase Plans StockPurchasedAndIssuedDuringPeriodSharesEmployeeStockPurchasePlans	67094	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	15129537	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	12106977	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3022560	shares
CY2019Q4	pcrx	Employee Stock Purchase Plan Numberof Shares Authorized EmployeeStockPurchasePlanNumberofSharesAuthorized	500000	shares
CY2019	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	291981	shares
CY2019Q4	pcrx	Employee Stock Purchase Plan Numberof Shares Available For Purchase EmployeeStockPurchasePlanNumberofSharesAvailableForPurchase	208019	shares
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33650000	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31725000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31601000	USD
CY2019	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	23360000	USD
CY2018	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	22643000	USD
CY2017	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	24223000	USD
CY2019	us-gaap	Restricted Stock Expense RestrictedStockExpense	9511000	USD
CY2018	us-gaap	Restricted Stock Expense RestrictedStockExpense	8371000	USD
CY2017	us-gaap	Restricted Stock Expense RestrictedStockExpense	6698000	USD
CY2019	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	779000	USD
CY2018	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	711000	USD
CY2017	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	680000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	33650000	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	31725000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	31601000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-11016000	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-471000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-42611000	USD
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41513000	shares
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	40911000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39806000	shares
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.27
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.07
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7044000	shares
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6065000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6060000	shares
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-71000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	5169000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-39898000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-10677000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-5594000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2573000	USD
CY2019	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-10748000	USD
CY2018	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-425000	USD
CY2017	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-42471000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-96000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	0	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	2096000	USD
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	142000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	140000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2096000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	46000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	140000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1828000	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1828000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	268000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	46000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	140000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.3500
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0733
CY2018	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.2484
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0226
CY2019	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0395
CY2018	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.9204
CY2017	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0128
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1976
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	3.6927
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0458
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.1053
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	8.7429
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0121
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.1993
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-7.0035
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0496
CY2019	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0
CY2018	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	2.1847
CY2017	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0.0290
CY2019	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	-0.0042
CY2018	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	0.1344
CY2017	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	-1.3088
CY2019	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0
CY2018	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0
CY2018Q3	us-gaap	Cost Of Revenue CostOfRevenue	19065000	USD
CY2017	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0.0655
CY2018Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	848000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2022000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	127000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	134057000	USD
CY2019	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0
CY2018	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0
CY2017	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0.6889
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-0.1358
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	-1.3296
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0
CY2019	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-0.1541
CY2018	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-2.0298
CY2017	pcrx	Effective Income Tax Rate Reconciliation Tax Reserves Percent EffectiveIncomeTaxRateReconciliationTaxReservesPercent	-0.0247
CY2019	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	-0.0961
CY2018	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	0
CY2017	pcrx	Effective Income Tax Rate Reconciliation338g Election Percent EffectiveIncomeTaxRateReconciliation338gElectionPercent	0
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0235
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.0615
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.1037
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0249
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1073
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0033
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0249
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.1073
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0033
CY2019	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.210
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	66638000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	79446000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	16895000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	17730000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	16541000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2851000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	8756000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	11009000	USD
CY2019Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	21663000	USD
CY2018Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	18302000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1542000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	125674000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	118658000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2019Q4	pcrx	Non Us Net Operating Loss NonUSNetOperatingLoss	13600000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	130313000	USD
CY2019Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	8383000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	11655000	USD
CY2019Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	125674000	USD
CY2018Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	118658000	USD
CY2019	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.50
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	7000000.0	USD
CY2019	pcrx	Tax Cutsand Jobs Actof2017 Changein Tax Rate Income Tax Expense Benefit TaxCutsandJobsActof2017ChangeinTaxRateIncomeTaxExpenseBenefit	55700000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1700000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4500000	USD
CY2018	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-1600000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2881000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1656000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4537000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2600000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1600000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	USD
CY2019	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	200000	USD
CY2018	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	1600000	USD
CY2017	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	5400000	USD
CY2019	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	5300000	USD
CY2016Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2016Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	0	USD
CY2016Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	0	USD
CY2016Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	0	USD
CY2017	us-gaap	Severance Costs1 SeveranceCosts1	303000	USD
CY2017	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	2018000	USD
CY2017	pcrx	Discontinued Operations Fixed Assetand Inventory Writedown DiscontinuedOperationsFixedAssetandInventoryWritedown	-2470000	USD
CY2017	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	656000	USD
CY2017	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-5447000	USD
CY2017	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	303000	USD
CY2017	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	744000	USD
CY2017	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	420000	USD
CY2017	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1467000	USD
CY2017	pcrx	Discontinued Operations Assetsremovedfrom Service DiscontinuedOperationsAssetsremovedfromService	2470000	USD
CY2017	pcrx	Discontinued Operations Assetsremovedfrom Service DiscontinuedOperationsAssetsremovedfromService	2470000	USD
CY2017	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	494000	USD
CY2017	pcrx	Asset Retirement Obligation Reclassification AssetRetirementObligationReclassification	73000	USD
CY2017	us-gaap	Business Exit Costs1 BusinessExitCosts1	567000	USD
CY2017Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2017Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1768000	USD
CY2017Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	309000	USD
CY2017Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	2077000	USD
CY2018	us-gaap	Severance Costs1 SeveranceCosts1	0	USD
CY2018	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	-1513000	USD
CY2018	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	51000	USD
CY2018	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-1564000	USD
CY2018	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	0	USD
CY2018	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	1311000	USD
CY2018	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	91000	USD
CY2018	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1402000	USD
CY2018	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	0	USD
CY2018	pcrx	Asset Retirement Obligation Reclassification AssetRetirementObligationReclassification	13000	USD
CY2018	us-gaap	Business Exit Costs1 BusinessExitCosts1	13000	USD
CY2018Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2018Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1970000	USD
CY2018Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	282000	USD
CY2018Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	2252000	USD
CY2019	us-gaap	Severance Costs1 SeveranceCosts1	429000	USD
CY2019	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	0	USD
CY2019	pcrx	Discontinued Operations Fixed Assetand Inventory Writedown DiscontinuedOperationsFixedAssetandInventoryWritedown	-193000	USD
CY2019	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	225000	USD
CY2019	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-847000	USD
CY2019	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	348000	USD
CY2019	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	0	USD
CY2019	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	404000	USD
CY2019	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	-752000	USD
CY2019	pcrx	Discontinued Operations Assetsremovedfrom Service DiscontinuedOperationsAssetsremovedfromService	193000	USD
CY2019	pcrx	Asset Retirement Obligation Other Period Increase Decrease AssetRetirementObligationOtherPeriodIncreaseDecrease	0	USD
CY2019	us-gaap	Disposal Group Including Discontinued Operation Other Expense DisposalGroupIncludingDiscontinuedOperationOtherExpense	193000	USD
CY2019	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	-1970000	USD
CY2019	pcrx	Asset Retirement Obligation Reclassification AssetRetirementObligationReclassification	455000	USD
CY2019	us-gaap	Business Exit Costs1 BusinessExitCosts1	-1515000	USD
CY2019Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	81000	USD
CY2019Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	558000	USD
CY2019Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	639000	USD
CY2019Q4	us-gaap	Litigation Settlement Amount Awarded To Other Party LitigationSettlementAmountAwardedToOtherParty	3500000	USD
CY2019Q1	us-gaap	Revenues Revenues	91313000	USD
CY2019Q2	us-gaap	Revenues Revenues	102604000	USD
CY2019Q3	us-gaap	Revenues Revenues	104685000	USD
CY2019Q4	us-gaap	Revenues Revenues	122424000	USD
CY2019Q1	us-gaap	Cost Of Revenue CostOfRevenue	27303000	USD
CY2019Q2	us-gaap	Cost Of Revenue CostOfRevenue	25201000	USD
CY2019Q3	us-gaap	Cost Of Revenue CostOfRevenue	22304000	USD
CY2019Q4	us-gaap	Cost Of Revenue CostOfRevenue	31904000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	90234000	USD
CY2019Q2	us-gaap	Operating Expenses OperatingExpenses	97329000	USD
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	102272000	USD
CY2019Q4	us-gaap	Operating Expenses OperatingExpenses	120711000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-2771000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	2730000	USD
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-6087000	USD
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	-4888000	USD
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.06
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2018Q1	us-gaap	Revenues Revenues	74607000	USD
CY2018Q2	us-gaap	Revenues Revenues	84107000	USD
CY2018Q3	us-gaap	Revenues Revenues	83448000	USD
CY2018Q4	us-gaap	Revenues Revenues	95115000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	22885000	USD
CY2018Q2	us-gaap	Cost Of Revenue CostOfRevenue	20916000	USD
CY2018Q4	us-gaap	Operating Expenses OperatingExpenses	82852000	USD
CY2018Q4	us-gaap	Cost Of Revenue CostOfRevenue	23979000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	81544000	USD
CY2018Q2	us-gaap	Operating Expenses OperatingExpenses	77566000	USD
CY2018Q3	us-gaap	Operating Expenses OperatingExpenses	79400000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2018Q2	us-gaap	Net Income Loss NetIncomeLoss	2564000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	-640000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	8285000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2018Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
CY2018Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2018Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.20

Files In Submission

Name	View Source	Status
0001396814-20-000008-index-headers.html	Edgar Link	pending
0001396814-20-000008-index.html	Edgar Link	pending
0001396814-20-000008.txt	Edgar Link	pending
0001396814-20-000008-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
item5chart2019.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pacirabiosciencesa02.jpg	Edgar Link	pending
pcrx-12312019x10k.htm	Edgar Link	pending
pcrx-12312019x10k_htm.xml	Edgar Link	completed
pcrx-12312019xex211.htm	Edgar Link	pending
pcrx-12312019xex231.htm	Edgar Link	pending
pcrx-12312019xex311.htm	Edgar Link	pending
pcrx-12312019xex312.htm	Edgar Link	pending
pcrx-12312019xex321.htm	Edgar Link	pending
pcrx-12312019xex43.htm	Edgar Link	pending
pcrx-20191231.xsd	Edgar Link	pending
pcrx-20191231_cal.xml	Edgar Link	unprocessable
pcrx-20191231_def.xml	Edgar Link	unprocessable
pcrx-20191231_lab.xml	Edgar Link	unprocessable
pcrx-20191231_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2019 Q4 Form 10-K Financial Statement

#000139681420000008 Filed on February 21, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2019 Q4 Form 10-K Financial Statement

#000139681420000008 Filed on February 21, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx